Showing results (1291-1300 of 1,303) with videos related to
Sort By:
Pageof 131
JAMA Ophthalmology|November 11, 2021
Defining High-risk Retinoblastoma: A Multicenter Global SurveySwathi Kaliki, Carol L Shields, Nathalie Cassoux, et al.Retina (Philadelphia, Pa.)|December 2, 2024
NEOVASCULAR GLAUCOMA AS A PREDICTOR OF RETINOBLASTOMA HIGH-RISK HISTOPATHOLOGY IN AN INTERNATIONAL MULTICENTER STUDYGuy S Negretti, Tatiana Ushakova, Serov Yuri, et al.Ophthalmology. Retina|June 12, 2022
The Prevalence of Retinal Disease and Associated CNS Disease in Young Patients with Incontinentia PigmentiIan D Danford, Brittni A Scruggs, Antonio Capone, et al.Peerj|November 6, 2019
Worldwide inequality in access to full text scientific articles: the example of ophthalmologyChristophe Boudry, Patricio Alvarez-Muñoz, Ricardo Arencibia-Jorge, et al.Cell Reports|November 16, 2017
Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell LinesBradley Garman, Ioannis N Anastopoulos, Clemens Krepler, et al.American Journal of Ophthalmology|September 27, 2024
Treatment Outcomes and Definition Inconsistencies in High-Risk Unilateral RetinoblastomaMattan Arazi, Alona Baum, Sandro Casavilca-Zambrano, et al.International Journal of Ophthalmology|July 22, 2017
An international survey of classification and treatment choices for group D retinoblastomaChristina Scelfo, Jasmine H Francis, Vikas Khetan, et al.Cell Host & Microbe|January 11, 2019
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine DesignChristine A Bricault, Karina Yusim, Michael S Seaman, et al.Cell Reports|November 16, 2017
A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of MelanomaClemens Krepler, Katrin Sproesser, Patricia Brafford, et al.The Lancet. Oncology|December 5, 2019
Sebaceous carcinoma: evidence-based clinical practice guidelinesJoshua L Owen, Nour Kibbi, Brandon Worley, et al.Pageof 131